Zacks Investment Research Upgrades LHC Group (NASDAQ:LHCG) to Buy
LHC Group (NASDAQ:LHCG) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday, Zacks.com reports. The firm presently has a $124.00 price target on the health services provider’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 4.69% from the stock’s current price.
According to Zacks, “LHC Group continues to benefit from its home health services and hospice admissions, which have witnessed solid year-over-year growth. Management is optimistic about strong synergies from the Almost Family acquisition, which has proven accretive in the last reported quarter. The company is also anticipated to gain from joint ventures. Strong guidance for 2019 paints a bright picture about the rest of the year. The stock has outperformed the industry in a year’s time. LHC Group exited the second quarter on a mixed note, wherein the earnings beat the consensus mark, while revenues missed the same. Meanwhile, a highly competitive home healthcare market adds to woes. Regulatory headwinds also raise concern. The stock is overvalued at the moment.”
Several other research firms also recently commented on LHCG. BidaskClub downgraded shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Oppenheimer boosted their price objective on shares of LHC Group from $125.00 to $146.00 and gave the stock an “outperform” rating in a research note on Friday, August 9th. Barclays boosted their price objective on shares of LHC Group from $113.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, August 9th. Royal Bank of Canada set a $135.00 price objective on shares of LHC Group and gave the stock a “buy” rating in a research note on Friday, August 9th. Finally, Deutsche Bank began coverage on shares of LHC Group in a research note on Monday. They issued a “buy” rating and a $145.00 price objective for the company. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $129.70.
LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, August 7th. The health services provider reported $1.07 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.01 by $0.06. The company had revenue of $517.84 million during the quarter, compared to the consensus estimate of $524.24 million. LHC Group had a net margin of 4.20% and a return on equity of 8.83%. The company’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.84 earnings per share. Sell-side analysts expect that LHC Group will post 4.34 earnings per share for the current year.
Institutional investors have recently modified their holdings of the company. Atria Investments LLC acquired a new position in LHC Group during the second quarter worth about $686,000. BlackRock Inc. grew its stake in LHC Group by 5.9% in the second quarter. BlackRock Inc. now owns 4,960,615 shares of the health services provider’s stock worth $593,191,000 after purchasing an additional 274,262 shares in the last quarter. BRYN MAWR TRUST Co grew its stake in LHC Group by 3.7% in the second quarter. BRYN MAWR TRUST Co now owns 39,765 shares of the health services provider’s stock worth $4,755,000 after purchasing an additional 1,428 shares in the last quarter. Security National Trust Co. bought a new position in LHC Group in the second quarter worth approximately $120,000. Finally, Voloridge Investment Management LLC grew its stake in LHC Group by 42.2% in the second quarter. Voloridge Investment Management LLC now owns 34,978 shares of the health services provider’s stock worth $4,183,000 after purchasing an additional 10,387 shares in the last quarter. Institutional investors and hedge funds own 90.15% of the company’s stock.
About LHC Group
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Read More: What is the Book Value of a Share?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.